Home » Topics » Regulatory » Patents

Patents
RSS

AbbVie Sarl, Galapagos identify novel CFTR modulators

Dec. 18, 2017

Chiesi patents neutrophil elastase inhibitors

Dec. 18, 2017

Novel IRAK inhibitors discovered at Pharmacyclics

Dec. 18, 2017

Novel PROTAC compounds presented by KRICT

Dec. 15, 2017

Merck KGaA presents new ATR kinase inhibitors

Dec. 15, 2017

Novel P2RX2/P2RX3 antagonists presented by Shionogi

Dec. 15, 2017

SIMM presents novel FGFR inhibitors

Dec. 15, 2017

Roche patents xanthone derivatives for HBV

Dec. 15, 2017

Idera Pharmaceuticals patents antisense oligonucleotides for cancer

Dec. 14, 2017

SLC22A12 inhibitors described in Institute of Materia Medica of Beijing patent

Dec. 14, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...